Efficacy and Safety of 2 Secukinumab Regimens in 90kg or More Weight Group With Moderate/Severe Chronic Plaque Psoriasis
Clinical trial NCT03504852 · COMPLETED
Trial details
- NCT number
- NCT03504852
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-25
- Primary completion
- 2019-09-13
- Enrollment
- 331
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.